Posts

Posted on

Teledyne Demonstrates Autonomous System for Anti-Submarine Warfare to NATO Members in the North Atlantic

Teledyne Demonstrates Autonomous System for Anti-Submarine Warfare to NATO Members in the North Atlantic

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–
Teledyne Technologies Incorporated (NYSE:TDY) today announced that, from January 17 through January 22, it conducted an Anti-Submarine Warfare (ASW) demonstration in Icelandic waters using its state-of-the-art autonomous underwater vehicles:

  • Slocum Sentinel Glider with a 60-meter-long passive acoustic towed array

  • Slocum G3 Glider with integrated Teledyne Benthos acoustic communications

  • Two Advanced Profiling Explorer (APEX) floats fitted with ambient noise Passive Acoustic Monitoring

Several NATO members were in attendance to witness the trials which were conducted from the Teledyne Gavia facility located in Kópavogur, Iceland. “We are pleased to be demonstrating this technology which helps address a critical issue for global security,” said George Bobb, President and Chief Executive Officer of Teledyne. “We are excited to show what is possible with proven, mature, commercial technology currently in use by NATO militaries.”

With assistance from the Icelandic Coast Guard, the Teledyne team was able to deploy the autonomous underwater gliders into the North Atlantic in the strategic Greenland – Iceland gap from the Coast Guard Ship ICGV Þór. The Sentinel Glider towed a passive acoustic thin-line hydrophone array specifically designed to identify surface and subsurface vehicle noise in the water. The silent autonomous gliders, transversing the water column to 1,000 meters and equipped with the sensitive passive acoustic array, create a formidable barrier for subsea adversaries.

In addition to acoustic payloads, Teledyne demonstrated the ability for its glider to acoustically exfiltrate data from a sea-bottom node, deployed as part of the demonstration. Simulated mission data was recovered from the node in real-time and later transmitted via satellite to the shore-based Mission Operations Control Centers in Iceland and the United Kingdom. “This result showcases our ability to meet a large percentage of existing requirements for conducting ASW with autonomous systems in the North Atlantic,” said Dan Shropshire, Vice President of Business Development for Teledyne Marine Vehicles and project lead. “The combination of our platforms with advanced sensor technologies, including the use of artificial intelligence and machine learning, allows us to bring a force multiplier to militaries world-wide, but at a fraction of the operational expense.”

In addition to the technical demonstration, Teledyne highlighted the ability to establish a Remote Operations Center with help from its long-time partner at the National Oceanographic Centre (NOC) in the United Kingdom, where Teledyne has a European Glider service and repair center. The gliders were piloted in tandem with Iceland from the NOC. Data was retrieved and displayed from the subsea node for use simultaneously at both Operations Center locations. “Teledyne already has a large footprint in the U.K. with 18 principal facilities and approximately 2,600 employees,” said Brian Maguire, Teledyne Marine Chief Operating Officer. “We are investing even more significantly to bring autonomous technology to the Ministry of Defense and the Royal Navy.”

About Teledyne

Teledyne is a leading provider of sophisticated digital imaging products and software, instrumentation, aerospace and defense electronics, and engineered systems. Teledyne’s operations are primarily located in the United States, Canada, the United Kingdom, and Western and Northern Europe. For more information, visit Teledyne’s website at www.teledyne.com.

Contact:

Jason VanWees

(805) 373-4542

KEYWORDS: North America United States United Kingdom Europe Iceland California

INDUSTRY KEYWORDS: Other Defense Contracts Technology Defense Security Public Relations/Investor Relations Government Technology Air Communications Transport Aerospace Military Manufacturing

MEDIA:

Logo
Logo
Posted on

ACI Worldwide Report: Global Refund Volumes Surge 18% as Retailers Tighten Returns

ACI Worldwide Report: Global Refund Volumes Surge 18% as Retailers Tighten Returns

New analysis shows holiday-driven refund growth, rising fraud risk, and growing pressure on retail margins despite strong eCommerce growth

OMAHA, Neb. & LONDON–(BUSINESS WIRE)–
Annual refund volumes in the global retail sector increased 18.1 % in 2025, while refund value rose 12.7% year-on-year, according to ACI’s annual Global Ecommerce Report. ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, analysed billions of retail transactions worldwide as part of the study.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260202280601/en/

Refund activity peaked sharply during the holiday season; November and December together accounted for approximately 20% of all refunds in 2025. December alone recorded a 2.89% refund rate, meaning nearly three out of every 100 purchases resulted in a return, compared with an average refund rate of 2.25% between January and October.

The findings come amid continued growth in global eCommerce. Across all retail sectors, eCommerce transaction volumes grew 28.3% in 2025, while total transaction value increased 34.3% year-on-year, driven by consumer demand for convenience, sustained innovation across the retail ecosystem, and rising levels of consumer trust.

While refund rates are rising more slowly than eCommerce transactions, their financial impact for retailers remains significant. Every $1 million in refunds typically translates into around $1.3 million in total costs once reverse logistics, inventory depreciation, payment processing fees, and fraud-related overheads are accounted for.

As refund volumes accelerate, retailers are rethinking their approach to returns and fraud management. This includes deploying AI-driven identity verification, real-time monitoring, and tighter, more adaptive return policies. Increasingly, merchants are applying real-time analytics traditionally reserved for fraud prevention to refund and return activity—seeking to reduce abuse while preserving a frictionless experience for legitimate customers.

“The sharp rise in refund volumes is exposing a growing pressure point for retailers—one that directly threatens margins, especially during peak periods and extended return windows,” said Adriana Iordan, head of merchant product management and payments intelligence at ACI Worldwide. “Retailers need smarter, AI‑driven controls that spot abuse in real time and adapt policies dynamically, without adding friction for genuine customers. By bringing fraud and refund management together, merchants can curb losses, protect profitability, and still deliver a customer seamless experience—even as refund volumes continue to climb.”

Key Highlights at a Glance (Year‑on‑Year, Retail)

  • Refund Growth: Refund transactions increased 18.1%, while refund value rose 12.7%, indicating higher refund frequency but lower average refund values.
  • Holiday Surge: November and December together accounted for ~20% of annual refunds, driven by extended return windows and elevated fraud risk.
  • Refund‑to‑Payment Ratio: Averaged 2.5%–3% across the year, highlighting growing pressure within omnichannel retail environments.
    • January–October: 2.25%

    • November: 2.28%

    • December: 2.89%

  • Payment Expansion: eCommerce payment volumes increased 28.3%, with transaction values up 34.3%, reflecting sustained consumer spending growth.
  • Strategic Implications: The widening gap between payment growth and refund growth underscores the opportunity for retailers to tighten refund controls without eroding customer experience—particularly during peak periods.

About the Report:

ACI’s Global Annual Ecommerce Report provides insight on the latest eCommerce trends based on an analysis of billions of global retail transactions processed in 2024 and 2025.

About ACI Worldwide

ACI Worldwide, an original innovator in global payments technology, delivers transformative software solutions that power intelligent payments orchestration in real time so banks, billers and merchants can drive growth, while continuously modernizing their payment infrastructures, simply and securely. With nearly 50 years of trusted payments expertise, we combine our global footprint with a local presence to offer enhanced payment experiences to stay ahead of constantly changing payment challenges and opportunities.

© Copyright ACI Worldwide, Inc. 2026

ACI, ACI Worldwide, ACI Payments, Inc., ACI Pay, Speedpay, and all ACI product/solution names are trademarks or registered trademarks of ACI Worldwide, Inc., or one of its subsidiaries, in the United States, other countries, or both. Other parties’ trademarks referenced are the property of their respective owners.

Media


Katrin Boettger | Communications and Corporate Affairs Director | [email protected]

Pierce Rohrmann I Head of Communications and Corporate Affairs I [email protected]

KEYWORDS: Europe United States United Kingdom North America Nebraska

INDUSTRY KEYWORDS: Technology Payments Finance Other Retail Electronic Commerce Professional Services Software Retail Online Retail

MEDIA:

Photo
Photo
Logo
Logo
Posted on

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day

  • Highlights advancing clinical-stage pipeline, including two major value-creating programs for primary immunodeficiencies (PIDs) with immune dysregulation and mtDNA-driven mitochondrial disease
  • Introduces napazimone (KL1333) as the compound name for the mtDNA-driven mitochondrial disease program
  • 2026 total revenue guidance of US$405 – US$425 million (8% to 13% growth)
  • 2026 total operating expense guidance of US$330 – US$335 million
  • Investor Day will be webcast today starting at 10:00 am EST (16:00 CET)

Leiden, The Netherlands, February 3, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced 2026 financial guidance and will highlight its advancing clinical-stage rare disease pipeline, including two major value-creating programs, at a virtual Investor Day taking place later today.

The Investor Day will focus on the scientific rationale, clinical strategy, and long‑term opportunity underpinning Pharming’s pipeline programs in primary immunodeficiencies (PIDs) with immune dysregulation and mitochondrial DNA (mtDNA)‑driven mitochondrial disease.

Fabrice Chouraqui, Chief Executive Officer of Pharming, commented:

“Pharming’s vision of developing into a leading global rare disease company is grounded in the strength of our two commercial products and our high-value pipeline. We expect our commercial portfolio to continue delivering robust growth, with total revenues between US$405 million and US$425 million in 2026. We are excited to showcase the breadth and quality of our pipeline at today’s Investor Day. Leniolisib and napazimone (KL1333) are being developed for large, underserved rare disease populations with significant unmet need, and are supported by a strong and growing body of biological and clinical evidence. We believe both programs offer substantial long‑term value‑creating potential for Pharming.”

  
2026 financial guidance:

  • Total revenues between US$405 million and US$425 million (8% to 13% growth), driven by significant and accelerating growth for Joenja® and continued growth for RUCONEST®
  • Total operating expenses between US$330 million and US$335 million, with the increase driven primarily by an increase in Research & Development expenses related to the ongoing leniolisib Phase II clinical trials and the napazimone (KL1333) pivotal clinical trial

Pipeline overview:

Leniolisib –
primary immunodeficiencies with immune dysregulation

Pharming management will outline the scientific and clinical rationale supporting the expansion of leniolisib into broader patient populations with primary immunodeficiencies (PIDs) with immune dysregulation, beyond its currently approved indication. Two Phase II proof‑of‑concept clinical trials are ongoing — one in genetically defined PIDs linked to PI3K signaling and one in common variable immunodeficiency (CVID) with immune dysregulation — with top‑line data for both trials expected in the second half of 2026.

Leniolisib is an oral, selective phosphoinositide 3‑kinase delta (PI3Kδ) inhibitor that is currently approved and marketed as Joenja in the United States, and marketed and/or approved in additional countries, as the first and only targeted treatment for activated PI3Kδ syndrome (APDS)1, a rare and progressive primary immunodeficiency, for patients 12 years of age and older. APDS represents a genetically defined form within the broader CVID spectrum and serves as a clinically validated proof‑of‑concept for targeting PI3Kδ‑driven immune dysregulation, supporting the potential applicability of leniolisib across significantly broader PID and CVID patient populations.

Napazimone (KL1333)–
mtDNA-driven mitochondrial disease

Pharming management will outline the scientific and clinical rationale for napazimone (KL1333), the newly named compound being developed for mtDNA-driven mitochondrial disease, which has the potential to become the first standard of care in this setting, if approved. The pivotal FALCON clinical trial is ongoing and remains on track for a readout in 2027.

Napazimone (KL1333) is an investigational therapy being developed for adult patients with primary mitochondrial disease caused by mitochondrial DNA (mtDNA) mutations — a rare and debilitating condition characterized by impaired energy production, significant fatigue and muscle weakness (myopathy), and reduced life expectancy.

Clinical expert perspectives

The Investor Day will feature presentations from leading clinical experts, providing context on disease biology, unmet medical need, and the potential role of Pharming’s programs.

  • Jocelyn Farmer, MD, PhD, Lahey Hospital & Medical Center — an internationally recognized authority on CVID and immune dysregulation
  • Amel Karaa, MD, Massachusetts General Hospital, Harvard Medical School — an internationally recognized authority on mitochondrial medicine

Investor Day webcast information:

The Investor Day event will be held today, Tuesday, February 3, from 10:00 a.m. to 12:00 p.m. EST (16:00 to 18:00 CET). To register for and view the live event, please visit: https://www.pharming.com/pharming-investor-day-2026.

A replay will be available on the Pharming.com website shortly after the conclusion of the event.

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.

For more information, visit www.pharming.com and find us on LinkedIn.

Forward-looking Statements

This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. These forward-looking statements are identified by their use of terms and phrases such as “aim”, “ambition”, ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’, ‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, “milestones”, ‘‘objectives’’, ‘‘outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “schedule”, ‘‘seek’’, ‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases. Examples of forward-looking statements may include statements with respect to timing and progress of Pharming’s preclinical studies and clinical trials of its product candidates, Pharming’s clinical and commercial prospects, and Pharming’s expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming’s clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory, commercial, competitive and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming’s 2024 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming’s actual results could differ materially and adversely from those anticipated or implied thereby. All forward-looking statements contained in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release. Pharming does not undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information.

Inside Information

This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

For further public information, contact:

Investor Relations

Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: [email protected]

Media Relations

Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: [email protected]

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

1 FDA press release published on March 24, 2023, titled FDA approves first treatment for activated phosphoinositide 3-kinase delta syndrome. Available via: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-activated-phosphoinositide-3-kinase-delta-syndrome

Attachment



Posted on

WISeKey to ConnectWISeRobot.CH to the WISeSat.Space Constellation protected by SEALSQ Post-Quantum Cryptography;

WISeKey to ConnectWISeRobot.CH to the WISeSat.Space Constellation protected by SEALSQ Post-Quantum Cryptography;

The Robot PoC will be showcased at WISeKEY’s CEO Carlos Moreira’s next public appearance in France at Tech & Fest


Video link is available at



https://youtube.com/shorts/XsVQlcDtfTQ

Geneva, Switzerland — February 3, 2026 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces that during the next WISeSat launch scheduled for the second quarter of 2026, it will be demonstrating the connection of its WISeRobot to the WISeSat.Space satellite constellation through a post-quantum cryptography (PQC)–secured communication link provided by its subsidiary, SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products. This PoC marks a world-first in robotics, combining space-based connectivity, quantum-resilient cybersecurity, secure digital identity, and value-centric artificial intelligence within a single autonomous system.

The WISeRobot Project is an ambitious initiative that aims to create the world’s first post-quantum–secure robot explicitly designed to embed human values at its core. It will illustrate the convergence of advanced robotics, artificial intelligence, secure semiconductors, decentralized technologies, and ethical governance, with the objective of ensuring that intelligent machines evolve in alignment with humanity rather than independently of it.

By leveraging the WISeSat.Space constellation, WISeRobot will gain access to resilient, sovereign, and secure satellite communications protected against both classical and future quantum threats. The connection will be secured using post-quantum–ready cryptographic technologies embedded directly into the hardware and software architecture, ensuring the integrity, authenticity, and confidentiality of data exchanges across terrestrial and space-based infrastructures.

At the heart of WISeRobot concept will be the secure digital identity anchored in post-quantum–resistant chips that provide cryptographic roots of trust. These roots of trust will protect the robot’s identity, communications, decision-making processes, and software integrity throughout its entire lifecycle. Security, accountability, and privacy are not to be treated as optional features, but as intrinsic properties of the system by design.

In addition, WISeRobot will integrate a native SEALCOIN wallet, enabling secure machine-to-machine (M2M) payments and economic interactions. This capability will allow WISeRobot to autonomously authenticate, transact, and settle services with other machines, devices, and digital infrastructures in a trusted and quantum-resilient manner. The integration of secure identity, post-quantum cryptography, and programmable payments lays the foundation for a new class of autonomous economic agents operating safely within regulated and auditable environments.

Beyond technological resilience, WISeRobot project has been conceived around a value-aware robotic platform vision. Human values such as dignity, fairness, transparency, justice, compassion, and respect for privacy are translated into concrete technical mechanisms, including value-aligned datasets, human-in-the-loop and human-in-command training models, explainable and auditable decision pathways, and enforceable ethical constraints governing autonomous behavior in real-world environments.

A defining feature of the project is verifiable identity and accountability. Each WISeRobot instance will be endowed with a secure digital identity that enables authenticated interactions with humans and other machines, traceability of actions, and compliance with regulatory, legal, and ethical frameworks. This approach ensures that responsibility remains clearly attributable at all times and that meaningful human oversight is preserved, even in highly autonomous operational contexts.

The WISeRobot Project also serves as a living laboratory for governance and policy innovation, supporting emerging international standards for trustworthy AI and robotics. It aligns with global efforts to establish ethical frameworks for artificial intelligence, including initiatives aimed at defining an ethical “constitution for AI” grounded in centuries of human wisdom and universal values.

The connection of WISeRobot to the WISeSat.Space constellation via a PQC-secured link, combined with secure digital identity and machine-to-machine payments, aims to demonstrates that the future of robotics does not require a trade-off between performance and principles. By integrating post-quantum security, satellite-based connectivity, decentralized economic capabilities, and human-centric AI, WISeRobot hopes to set a new global reference for intelligent machines that are powerful, resilient, economically autonomous, and fundamentally aligned with human dignity and trust.

Carlos Moreira, Founder and CEO WISeKey and SEALSQ said “We are incrementally expanding the capabilities of WISeRobot.CH, teaching it to perform new functions and reason at increasingly advanced levels. As part of its evolution, the robot is also being enriched with all content generated during our Davos roundtables, events in which WISeRobot actively participated, allowing it to internalize high-level technological, geopolitical, and ethical discussions. At the same time, we are actively working on integrating the QS7001 and connecting WISeRobot directly to the WISeSat constellation, providing secure, resilient, and sovereign communications. An advanced AI module has also been installed, enabling WISeRobot to answer expert-level questions related to post-quantum cryptography, quantum technologies, and cybersecurity.”

This Ai upgrade will be publicly demonstrated during the keynote I will deliver in Grenoble at the TechFest event in Grenoble this week https://www.tech-fest.fr/en .

About WISeKey

WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY) is a global leader in cybersecurity, digital identity, and IoT solutions platform. It operates as a Swiss-based holding company through several operational subsidiaries, each dedicated to specific aspects of its technology portfolio. The subsidiaries include (i) SEALSQ Corp (Nasdaq: LAES), which focuses on semiconductors, PKI, and post-quantum technology products, (ii) WISeKey SA which specializes in RoT and PKI solutions for secure authentication and identification in IoT, Blockchain, and AI, (iii) WISeSat AG which focuses on space technology for secure satellite communication, specifically for IoT applications, (iv) WISe.ART Corp which focuses on trusted blockchain NFTs and operates the WISe.ART marketplace for secure NFT transactions, and (v) SEALCOIN AG which focuses on decentralized physical internet with DePIN technology and house the development of the SEALCOIN platform.

Each subsidiary contributes to WISeKey’s mission of securing the internet while focusing on their respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeKey platform. WISeKey secures digital identity ecosystems for individuals and objects using Blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeKey plays a vital role in securing the Internet of Everything. The company’s semiconductors generate valuable Big Data that, when analyzed with AI, enable predictive equipment failure prevention. Trusted by the OISTE/WISeKey cryptographic Root of Trust, WISeKey provides secure authentication and identification for IoT, Blockchain, and AI applications. The WISeKey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeKey’s strategic direction and its subsidiary companies, please visit www.wisekey.com.

Disclaimer

This communication expressly or implicitly contains certain forward-looking statements concerning WISeKey International Holding Ltd and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of WISeKey International Holding Ltd to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. WISeKey International Holding Ltd is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of the Swiss Financial Services Act (“FinSA”), the FinSa’s predecessor legislation or advertising within the meaning of the FinSA. Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeKey.

Press and Investor Contacts

WISeKey International Holding Ltd

Company Contact: Carlos Moreira
Chairman & CEO
Tel: +41 22 594 3000
[email protected] 		 WISeKey Investor Relations (US) 

The Equity Group Inc.
Lena Cati
Tel: +1 212 836-9611
[email protected]

 



Posted on

e.l.f. Cosmetics Unveils Telenovela-Inspired Big Game Campaign Starring Melissa McCarthy Ahead of Halftime

e.l.f. Cosmetics Unveils Telenovela-Inspired Big Game Campaign Starring Melissa McCarthy Ahead of Halftime

e.l.f. is back at the Big Game highlighting e.l.f.’s Glow Reviver Lip Oil and celebrating positivity, inclusivity and accessibility

OAKLAND, Calif.–(BUSINESS WIRE)–
e.l.f. Cosmetics, a brand from e.l.f. Beauty (NYSE: ELF), a bold disruptor with a kind heart, announced today it will show up during the Big Game on Sunday, February, 8, 2026, with a telenovela-inspired campaign celebrating positivity, inclusivity and accessibility.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260202873348/en/

e.l.f. Cosmetics announced it will show up during the Big Game on Sunday, February, 8, 2026, with a telenovela-inspired campaign celebrating positivity, inclusivity and accessibility. The ad features Academy Award®–nominated actor and producer Melissa McCarthy, actor and TV doctor Nicholas Gonzalez, iconic telenovela villain Itatí Cantoral, and e.l.f. Glow Reviver Lip Oil.

e.l.f. Cosmetics announced it will show up during the Big Game on Sunday, February, 8, 2026, with a telenovela-inspired campaign celebrating positivity, inclusivity and accessibility. The ad features Academy Award®–nominated actor and producer Melissa McCarthy, actor and TV doctor Nicholas Gonzalez, iconic telenovela villain Itatí Cantoral, and e.l.f. Glow Reviver Lip Oil.

Starring Academy Award®–nominated actor and producer Melissa McCarthy, actor and TV doctor Nicholas Gonzalez, iconic telenovela villain Itatí Cantoral, and e.l.f. Glow Reviver Lip Oil, this dramatic telenovela parody delivers the perfect e.l.f. twist. Our “e.l.f.enovela” – aptly named “Melisa” (me-LEE-sa, said in a deep, deep voice) – opens with McCarthy’s character awakening in a hospital bed to discover she has only one day to learn Spanish before watching the biggest reggaeton concert in America. Her unlikely savior? e.l.f.’s Glow Reviver Lip Oil.

The campaign draws inspiration from a highly engaged cultural conversation surrounding the details of 2026’s Big Game entertainment programming, especially the halftime show. English-speaking communities embraced the idea of learning Spanish to be fully engaged with one of the most significant and shared-experience cultural events.

That was a perfect cue for e.l.f. and its mission to make the best of beauty accessible to every eye, lip and face to spring into action.

e.l.f. has a deep connection to its Latin and Hispanic community. Hispanic households represent 18% of e.l.f. buying households, 29% higher than the cosmetics category average. * To strengthen the community bond and celebrate their heritage, e.l.f. produces the telenovela series “Descubre e.l.f.ecto,” which is about to launch its new episodic content later in February, and produced the hit song “ojos.labios.cara” with artist Manuel Turizo – an anthem accompanied by a full-scale music video.

Together with Duolingo, the world’s leading mobile learning platform, we are democratizing access to language learning with an exclusive offer of a complimentary Super Duolingo subscription to all e.l.f. Beauty Squad loyalty members so they can learn Spanish without the ads. **

“Everything we do at e.l.f. marries having your head in the stars to dream big and putting your feet on the ground to make it happen. We dreamt of pairing the absurdly good benefits of Glow Reviver Lip Oil with the comedy powerhouse of Melissa McCarthy, and the antagonist superpower of telenovela royalty Itatí Cantoral during the most impactful cultural moment of the year. That wish comes true on Sunday when we show up to celebrate with our Latin and Hispanic community in a meaningful way,” said Kory Marchisotto, Chief Marketing Officer at e.l.f. Beauty.

The hero of the story is e.l.f.’s Glow Reviver Lip Oil, which has the perfect pout power for McCarthy’s Rs to roll off her tongue – and her ultra-glossy, juicy lips. Glow Reviver Lip Oil has been e.l.f.’s best-selling product the past two years in a row, with one sold every 2.4 seconds in 2025. ***

A beloved global icon known for her warmth, humor, and range across genres, McCarthy brings heart and authenticity to everything she does. Her latest collaboration with e.l.f. brings that same joyful spirit to a campaign that celebrates culture, connection, and fun.

“I’ve always believed that laughter is universal — it’s one of the most genuine ways we connect,” said McCarthy. “So teaming up with my new friends at e.l.f. and stepping into the dramatic world of telenovelas — a genre full of passion and heart — felt really special. Adding glossy, juicy lips to all that melodrama was unexpected, joyful, and just plain fun.”

“e.l.f. Cosmetics is a bold brand with such a fun sensibility that being invited into this campaign on one of the world’s biggest stages was an absolute honor,” said Gonzalez. “Getting to celebrate Latino storytelling through humor, heart, and a full-on telenovela lens – alongside someone as fearless as Melissa McCarthy – felt both meaningful and wildly fun.”

“It felt like a dream come true. I realized it wasn’t just a professional opportunity; it was a recognition of my journey and my roots,” said Cantoral. “Being a Latina on a stage this big, like the Big Game, means so much to me. e.l.f. represents progress. It shows that beauty can be powerful, inclusive, and accessible at the same time. Thank you e.l.f. y viva Mexico.”

“Melisa,” brought to life by e.l.f. partner agency 72andSunny Amsterdam, leans into genuine telenovela and soap opera production tropes, shot in 30 frames per second with hyper-saturated color and the most unnaturally even lighting imaginable – all adding to melodrama. It was directed by Tim Heidecker from Tim & Eric with creative consulting by Santiago Fabregas. Ellen K, the host of the Ellen K Morning Show, is the familiar voice on the radio.

The streaming spot on Peacock during the Big Game serves as the ignition point for the full campaign that will also span TV, social and digital channels.

The 2026 campaign builds on e.l.f.’s Big Game legacy:

  • In 2023, as one of the only beauty brands to participate, e.l.f. disrupted the space with a sticky advertisement demonstrating that beauty belongs everywhere

  • In 2024, “Judge Beauty” delivered the verdict that it’s a “crime” to overpay for makeup

  • In 2025, “the e.l.f.time show” was a multi-pronged, disruptive, never-before-seen Ultimate Watch Party with a live-production, second-screen experience

Be sure to tune in Sunday, February 8, 2026, on Peacock. Follow the conversation on Instagram, Facebook, TikTok and YouTube. Check out our Zero Distance interview with Cantoral on e.l.f.’s Substack later today.

Watch “Melisa” for the Big Game here.

* Circana Receipt Panel Complete Consumer –All Venues 52W Ending 12/29/2024

** The two-week promotion begins Feb. 3, 2026. The one-month Super Duolingo subscription is open to all e.l.f. Beauty Squad loyalty members. Sign up here.

*** L52WE Jan 3, 2026

About e.l.f. Cosmetics

e.l.f. Beauty (NYSE: ELF) is fueled by a belief that anything is e.l.f.ing possible. We are a different kind of company that disrupts norms, shapes culture and connects communities through positivity, inclusivity and accessibility. e.l.f. Cosmetics, our global flagship brand, makes the best of beauty accessible to every eye, lip and face by bringing together the best of beauty, culture and entertainment. Our superpower is delivering universally appealing, premium quality products at accessible prices that are e.l.f. clean and vegan, all double-certified by Leaping Bunny and PETA as cruelty free. We are proud to have products made in Fair Trade Certified™ facilities. Learn more at www.elfcosmetics.com.

Media

Hannah Rubin

[email protected]

KEYWORDS: California Latin America North America United States Mexico Central America

INDUSTRY KEYWORDS: Men Online Entertainment Sports Events/Concerts Lifestyle Consumer Football Cosmetics Celebrity Retail Women

MEDIA:

Photo
Photo
e.l.f. Cosmetics announced it will show up during the Big Game on Sunday, February, 8, 2026, with a telenovela-inspired campaign celebrating positivity, inclusivity and accessibility. The ad features Academy Award®–nominated actor and producer Melissa McCarthy, actor and TV doctor Nicholas Gonzalez, iconic telenovela villain Itatí Cantoral, and e.l.f. Glow Reviver Lip Oil.
Photo
Photo
e.l.f. Cosmetics announced it will show up during the Big Game on Sunday, February, 8, 2026, with a telenovela-inspired campaign celebrating positivity, inclusivity and accessibility. The ad features Academy Award®–nominated actor and producer Melissa McCarthy, actor and TV doctor Nicholas Gonzalez, iconic telenovela villain Itatí Cantoral, and e.l.f. Glow Reviver Lip Oil.
Photo
Photo
e.l.f. Cosmetics announced it will show up during the Big Game on Sunday, February, 8, 2026, with a telenovela-inspired campaign celebrating positivity, inclusivity and accessibility. The ad features Academy Award®–nominated actor and producer Melissa McCarthy, actor and TV doctor Nicholas Gonzalez, iconic telenovela villain Itatí Cantoral, and e.l.f. Glow Reviver Lip Oil.
Logo
Logo
Posted on

Asian Enterprises Shift to Managed, Internet-First Networks

Asian Enterprises Shift to Managed, Internet-First Networks

Companies adopt services based on SD-WAN, SASE architectures to control costs, ensure application performance across diverse infrastructures, ISG Provider Lens® report says

SYDNEY–(BUSINESS WIRE)–
Enterprises across Asia Pacific are modernizing enterprise networks with internet-first managed services spanning network, security and cloud operations to improve performance, resilience and governance, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.

The 2025 ISG Provider Lens® Enterprise Managed Network Services report for Asia Pacific finds that organizations are replacing legacy networks with software-defined wide area network (SD-WAN) and secure access service edge (SASE) architectures. As they expand distributed operations, enterprises face rising pressure to ensure consistent application performance, regulatory compliance and cyber resilience while controlling costs and managing skills shortages. These factors are accelerating demand for modern managed network models that support rapid change without sacrificing visibility or control.

“Networks are becoming a strategic foundation for digital operations rather than a static utility,” said Leon Platts, president, Network and Software Advisory, ISG. “As enterprises accelerate AI adoption, robotics, and automation, the network is critical for reliable performance, real-time decision-making and sustained productivity gains. Across Asia Pacific, organizations seek architectures that balance flexibility with predictable performance to support mission-critical workloads.”

Enterprises’ growing use of cloud-native applications and distributed workforces is increasing demand in Asia Pacific for internet-first SD-WAN and SASE architectures, the report says. These models reduce dependence on costly legacy circuits while improving agility across geographically fragmented environments. Organizations are using deterministic underlays only where required for regulatory, latency or resilience reasons. This approach allows enterprises to modernize incrementally while maintaining service consistency across markets with varying infrastructure maturity.

Enterprises in the region are turning to managed and co-managed network services as they address internal skills gaps and increasing multivendor complexity, ISG says. API-first, usage-based network-as-a-service (NaaS) consumption models are growing in importance as companies seek to modernize networks incrementally and shift spending from CapEx to OpEx, ISG says. Automation and AIOps are being applied to provisioning, application assurance and change management to reduce manual effort and error rates. Faster site deployments, lower total cost of ownership and more predictable network performance are among the enterprise benefits of these advances.

There is a growing market in Asia Pacific for local managed network service providers that specialize in operating within sovereign boundaries, the report says. These providers work closely with customers, especially government bodies and private players, offering flexible co-managed models that are aligned with local regulations. They often maintain wholesale arrangements with national telcos while providing intent-based provisioning and real-time observability for quick recovery.

“Successful enterprises are rethinking network operations as a platform capability that underpins growth, customer experience and cost efficiency,” said Yash Jethani, principal analyst, ISG Provider Lens Research, and lead author of the report. “Modern managed network models enable organizations to scale digital initiatives while maintaining governance and service assurance.”

The report also explores additional trends affecting managed network adoption in Asia Pacific, including the growing importance of automation-led operations and the need to address variable last-mile performance and the complexity of edge connectivity.

For more insights into the network challenges facing enterprises in Asia Pacific, along with ISG’s advice for addressing them, see the ISG Provider Lens® Focal Points briefing here.

The 2025 ISG Provider Lens® Enterprise Managed Network Services report for Asia Pacific evaluates the capabilities of 63 providers across four quadrants: Managed Network Services Evolution, Managed Network Services — Local Specialist Providers, Managed Enterprise Connectivity Solutions (DIA, VoIP and VPN) and Network as a Service (NaaS).

The report names Accenture, GTT, NTT DATA, Orange Business, Singtel, Tata Communications, Telstra and Vodafone Business as Leaders in three quadrants each. It names PCCW Global and Verizon Business as Leaders in two quadrants each. BT, Data#3, Globe Business, Hitachi Digital Services, Interactive, KT, Logicalis, Maxis, Microland, SK Telecom, Spark NZ, StarHub, TCS, Telekom Malaysia (TM One), Vocus and Wipro are named as Leaders in one quadrant each.

In addition, Birlasoft, BT, HCLTech and Wipro are named as Rising Stars — companies with a “promising portfolio” and “high future potential” by ISG’s definition — in one quadrant each.

In the area of customer experience, Tata Communications is named the global ISG CX Star Performer for 2025 among Enterprise Managed Network Services providers. Tata Communications earned the highest customer satisfaction scores in ISG’s Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry.

The 2025 ISG Provider Lens® Enterprise Managed Network Services report for Asia Pacific is available to subscribers or for one-time purchase on this webpage.

About ISG Provider Lens™ Research

The ISG Provider Lens® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG’s global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG’s enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.

Press Contacts:

Laura Hupprich, ISG

+1 203-517-3100

[email protected]

Julianna Sheridan, Matter Communications for ISG

+1 978-518-4520

[email protected]

KEYWORDS: Australia/Oceania Australia Asia Pacific

INDUSTRY KEYWORDS: VoIP Software Networks Professional Services Internet Robotics Apps/Applications Technology Artificial Intelligence Security Data Analytics Consulting Telecommunications

MEDIA:

Logo
Logo
Posted on

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service

Addison, Texas, Feb. 02, 2026 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today announced the appointment of Jeb Terry, Sr to its Board of Directors and extended its sincere gratitude to Susanne Meline as she concluded her dedicated and influential board service. Both transitions are effective as of February 1, 2026.

Jeb Terry brings to the MDB board more than two decades of investment in microcap medical and biotechnology companies, where he has consistently identified and capitalized on high-potential opportunities in this dynamic and innovation-driven sector. He founded and served as President of Aberdeen Investment Management LLC from 2010 through 2025 where he led investment strategy and portfolio management with a sharp focus on undervalued microcap opportunities in life sciences. Drawing on a broad and distinguished career spanning venture capital, leveraged buyouts, and public equities, Mr. Terry brings a multifaceted perspective to investment decision-making.

“Jeb has been an active and avid supporter of MDB as we have grown from a private company to a publicly traded leader in public venture,” said Christopher Marlett, Co-founder and CEO of MDB. “We are excited to add his deep insight and sharp focus to our board as we continue to scale the platform and expand our founder and investor community.”

Concurrently, Susanne L. Meline concludes her service to the MDB board following years of invaluable leadership and guidance with a specialty in both finance and law. She will remain an enthusiastic shareholder and advocate of public venture for innovative, early-stage companies.

“We are deeply grateful to Susanne for all she has contributed to our board and the success of MDB,” said Christopher Marlett, Co-founder and CEO of MDB. “She has played an integral role in shaping the board’s impact and advising our leadership team as we transform how compelling technologies and companies are financed and commercialized through our platform.”

These transitions reflect MDB’s commitment to building a world-class leadership team to support its strategy of launching and scaling game-changing companies through its premier public venture platform.

About MDB Capital Holdings, LLC

Founded in 1997, MDB Capital focuses on launching “Big Ideas” through a unique approach to public venture capital. The firm emphasizes community-driven financings of early-stage leaders in significant business and technology categories via early public offerings, primarily on NASDAQ, as well as post-IPO offerings for qualifying companies. MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries—including MDB Capital, a venture-focused broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm—operate under the MDB Capital brand.

For more information, please visit www.mdb.com

Forward-Looking Statements

This press release contains “forward-looking statements.” These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall” and variations of these terms
or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB’s control. MDB’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB’s views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB’s views as of any date subsequent to the date of this press release.

Securities trading, account management, and investment banking services are offered by MDB Capital, a wholly owned subsidiary of MDB Capital Holdings, LLC (Nasdaq: MDBH) and a registered broker-dealer and member of FINRA and SIPC. Unless clearly stated, nothing herein shall be construed to be an offer to sell, nor a solicitation of an offer to buy, any financial product. For more information, please refer to MDB Capital’s Client Relationship Summary, or Form CRS, the uniform disclosure that provides succinct information about a firm’s services and responsibilities, fees and costs, and standards of conduct, at: https://www.mdb.com/disclosures/customer-relationship-summary/

Investor Relations Contact:

[email protected]

Media Contact:

[email protected] 



Posted on

CION Investment Corporation Announces Pricing of Public Offering of Unsecured Notes Due 2031

CION Investment Corporation Announces Pricing of Public Offering of Unsecured Notes Due 2031

NEW YORK–(BUSINESS WIRE)–
CION Investment Corporation (NYSE: CION) (the “Company” or “CION”) announced today that it has priced an underwritten public offering of $125.0 million aggregate principal amount of unsecured notes due 2031 (the “Notes”), which will result in net proceeds to the Company of approximately $121.25 million after the payment of underwriting discounts and commissions and not including estimated offering expenses payable by the Company. The Notes will mature on March 31, 2031 and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after March 31, 2028. The Notes will be issued in denominations of $25 and integral multiples of $25 in excess thereof and will bear interest at a rate of 7.50% per year, payable quarterly, with the first interest payment occurring on March 30, 2026. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional $18.75 million aggregate principal amount of Notes to cover overallotments, if any.

The offering is expected to close on February 9, 2026, subject to customary closing conditions. The Company intends to list the Notes on the New York Stock Exchange within 30 days of the original issue date.

The Company intends to use the net proceeds of the offering of the Notes to pay down borrowings under the Company’s senior secured credit facilities.

The joint book-running managers for the offering are Keefe, Bruyette & Woods, Inc., A Stifel Company, B. Riley Securities, Inc., Lucid Capital Markets, LLC and Oppenheimer & Co. Inc.

Investors are advised to carefully consider the investment objective, risks, charges and expenses of the Company before investing. The preliminary prospectus supplement dated February 2, 2026and the accompanying base prospectus dated June 18, 2024, which have been filed with the Securities and Exchange Commission (“SEC”), contain this and other information about the Company and should be read carefully before investing. The information in the preliminary prospectus supplement, the accompanying prospectus and this press release is not complete and may be changed.

A shelf registration statement relating to these securities is on file with and has been declared effective by the SEC. The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus, copies of which may be obtained from Keefe, Bruyette & Woods, Inc., 787 Seventh Avenue, Fourth Floor, New York, NY 10019 (telephone number 1-800-966-1559); copies may also be obtained by visiting EDGAR on the SEC’s website at http://www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities in this offering or any other securities nor will there be any sale of these securities or any other securities referred to in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

About CION Investment Corporation

CION Investment Corporation is a leading publicly listed business development company that had approximately $1.9 billion in total assets as of September 30, 2025. CION seeks to generate current income and, to a lesser extent, capital appreciation for investors by focusing primarily on senior secured loans to U.S. middle-market companies. CION is advised by CION Investment Management, LLC, a registered investment adviser and an affiliate of CION.

Forward-Looking Statements

This press release may contain forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “target,” “estimate,” “intend,” “continue,” or “believe” or the negatives thereof or other variations thereon or comparable terminology. You should read statements that contain these words carefully because they discuss CION’s plans, strategies, prospects and expectations concerning its business, operating results, financial condition and other similar matters. These statements represent CION’s belief regarding future events that, by their nature, are uncertain and outside of CION’s control. There are likely to be events in the future, however, that CION is not able to predict accurately or control. Any forward-looking statement made by CION in this press release speaks only as of the date on which it is made. Factors or events that could cause CION’s actual results to differ, possibly materially from its expectations, include, but are not limited to, the risks, uncertainties and other factors CION identifies in the sections entitled “Risk Factors” and “Forward-Looking Statements” in filings CION makes with the SEC, and it is not possible for CION to predict or identify all of them. CION undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Media

Susan Armstrong

[email protected]

Investor Relations

Charlie Arestia

[email protected]

(646) 253-8259

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

Logo
Logo
Posted on

Ellington Financial Announces the Income Tax Treatment of its 2025 Distributions

Ellington Financial Announces the Income Tax Treatment of its 2025 Distributions

OLD GREENWICH, Conn.–(BUSINESS WIRE)–
Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced that information regarding the federal income tax treatment of the distributions deemed paid in 2025 on the Company’s common and preferred stock has been posted to the Company’s website, at the following links.

Common Stock: https://ir.ellingtonfinancial.com/dividends-common-stock

Series A Preferred Stock: https://ir.ellingtonfinancial.com/dividends-preferred-stock

Series B Preferred Stock: https://ir.ellingtonfinancial.com/dividends-preferred-stock-series-b

Series C Preferred Stock: https://ir.ellingtonfinancial.com/dividends-preferred-stock-series-c

Series D Preferred Stock: https://ir.ellingtonfinancial.com/dividends-preferred-stock-series-d

About Ellington Financial

Ellington Financial invests in a diverse array of financial assets, including residential and commercial mortgage loans and mortgage-backed securities, reverse mortgage loans, mortgage servicing rights and related investments, consumer loans, asset-backed securities, collateralized loan obligations, non-mortgage and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments. Ellington Financial is externally managed and advised by Ellington Financial Management LLC, an affiliate of Ellington Management Group, L.L.C.

Investors:

Ellington Financial

Investor Relations

(203) 409-3575

[email protected]

or

Media:

Amanda Shpiner/Grace Cartwright

Gasthalter & Co.

for Ellington Financial

(212) 257-4170

[email protected]

KEYWORDS: United States North America Connecticut

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

Logo
Logo
Posted on

Ellington Credit Announces the Income Tax Treatment of its 2025 Distributions

Ellington Credit Announces the Income Tax Treatment of its 2025 Distributions

OLD GREENWICH, Conn.–(BUSINESS WIRE)–
Ellington Credit Company (NYSE: EARN) (the “Fund”) today announced that information regarding the federal income tax treatment of the distributions deemed paid in 2025 on the Fund’s common shares has been posted to the Fund’s website, at https://www.ellingtoncredit.com/dividend-and-tax-information. The Fund operated as a taxable C-Corp from January 1, 2025 to March 31, 2025, and has operated as a regulated investment company since April 1, 2025.

About Ellington Credit Company

Ellington Credit Company is a non-diversified closed-end fund that seeks to provide attractive current yields and risk-adjusted total returns by investing primarily in corporate collateralized loan obligations (“CLOs”), with a focus on mezzanine debt and equity tranches. The Fund is externally managed and advised by an affiliate of Ellington Management Group, L.L.C., a leading fixed-income investment manager founded in 1994. The Fund benefits from Ellington’s extensive experience and deep expertise in portfolio management, credit analysis, and risk management.

Investors:

Ellington Credit Company

Investor Relations

(203) 409-3773

[email protected]

or

Media:

Amanda Shpiner/Grace Cartwright

Gasthalter & Co.

for Ellington Credit Company

(212) 257-4170

[email protected]

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Logo
Logo